Intra-arterial Chemotherapy for Spinal Metastases

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2018

Study Completion Date

December 31, 2018

Conditions
Spinal DiseasesSpinal MetastasesSpinal Tumors
Interventions
DRUG

Melphalan (intra-arterial infusion)

"Patients will undergo a minimally invasive procedure called spinal angiography. This procedure will identify the arteries feeding the tumor causing cord compression and will determine whether chemotherapy can be safely infused.~The chemotherapy will be infused via a tiny soft plastic tube (called microcatheter) at the tumor site over approximately 30 minutes.~The drug of choice is melphalan (trade name Alkeran) at a maximum dose of 16mg/m2, adjusted for white cell count, platelet count and renal function.~We will perform up to three intra-arterial chemotherapy treatments in 3-6 week intervals, based on the results of complete blood counts."

Trial Locations (1)

10065

Weill Cornell Medical College Department of Neurological Surgery, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT01637766 - Intra-arterial Chemotherapy for Spinal Metastases | Biotech Hunter | Biotech Hunter